CGS 23885 is an orally active 5-lipoxygenase ( 5-lipoxygenase ) inhibitor. CGS 23885 reduces the production of 5-hydroxyeicosatetraenoic acid ( 5-hydroxyeicosatetraenoic acid ), LTB 4 , and LTC 4 /D 4 /E 4 . CGS 23885 inhibits cell infiltration in rat pleurisy. CGS 23885 can be used in pleurisy-related research.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Lipoxygenase | Products > Signaling Pathways > Leukotriene Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.